Home-based walking program for cancer patients undergoing chemotherapy
The Effect of Home-Based Walking Program on Peripheral Neuropathy, Fatigue and Quality of Life in Patients Receiving Taxane and Platinum-Based Chemotherapy
This study is testing if a home-based walking program can help cancer patients feel better and improve their quality of life while they are going through chemotherapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 86 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Akdeniz University Hospital Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Konyaaltı, Antalya) |
| Trial ID | NCT06012253 on ClinicalTrials.gov |
What this trial studies
This study evaluates the impact of a home-based walking program on patients experiencing peripheral neuropathy, fatigue, and quality of life while receiving taxane and platinum-based chemotherapy. It is a randomized controlled trial involving 86 cancer patients, divided into an intervention group that participates in an 8-week walking program and a control group. The program includes patient education, counseling, and regular follow-ups to monitor progress and outcomes. Various assessment tools will be utilized to collect data on toxicity, fatigue, and quality of life.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are Turkish-speaking and receiving taxane and platinum-based chemotherapy for the first time.
Not a fit: Patients with peripheral neuropathy from causes other than chemotherapy or those with significant health issues limiting mobility may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the quality of life and reduce fatigue for cancer patients undergoing chemotherapy.
How similar studies have performed: Other studies have shown positive outcomes with similar home-based exercise interventions for cancer patients, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
İnclusion Criteria * 18 Years and older (Adult, Older Adult ) * Turkish speaking-understanding ability and literate. * Orientation (person, place, time) * Receiving taxane and platinum-based chemotherapy treatment (monotherapy or combined). * Receiving chemotherapy treatment for the first time. * The primary medical diagnosis is cancer (breast cancer, colorectal cancers and other cancers). * Not having health problems that prevent walking. * Agreeing to participate in the research. Exclusion Criteria * Being bone and brain metastases * Being peripheral neuropathy due to reasons other than chemotherapy (such as chronic disease, diabetes mellitus, nutritional disorders) * Skin sensitivity on the hands and feet * Having cardiovascular, pulmonary, musculoskeletal, or psychological disorders that limit exercise or mobility * Being in another supportive program * Being in the very active category according to the "International Physical Activity Scale (IPAQ- Short Form)" * Being a severity of more than 4 points according to the "Modified Borg Scale (MBS)" * Being a score of 2 and above according to the "ECOG Performance Scale"
Where this trial is running
Konyaaltı, Antalya
- Akdeniz University — Konyaaltı, Antalya, Turkey (Recruiting)
Study contacts
- Study coordinator: Hava Kara
- Email: bilgin008@hotmail.com
- Phone: +905547267943
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.